Financing, Equity Capital Markets

Cardiff Oncology Inc.

09/20
|
$100.9 Million
Piper Sandler served as bookrunner for Cardiff Oncology, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma